Yun, U.-J.; Lee, I.H.; Lee, J.-S.; Shim, J.; Kim, Y.-N.
Ginsenoside Rp1, A Ginsenoside Derivative, Augments Anti-Cancer Effects of Actinomycin D via Downregulation of an AKT-SIRT1 Pathway. Cancers 2020, 12, 605.
https://doi.org/10.3390/cancers12030605
AMA Style
Yun U-J, Lee IH, Lee J-S, Shim J, Kim Y-N.
Ginsenoside Rp1, A Ginsenoside Derivative, Augments Anti-Cancer Effects of Actinomycin D via Downregulation of an AKT-SIRT1 Pathway. Cancers. 2020; 12(3):605.
https://doi.org/10.3390/cancers12030605
Chicago/Turabian Style
Yun, Un-Jung, In Hye Lee, Jae-Seon Lee, Jaegal Shim, and Yong-Nyun Kim.
2020. "Ginsenoside Rp1, A Ginsenoside Derivative, Augments Anti-Cancer Effects of Actinomycin D via Downregulation of an AKT-SIRT1 Pathway" Cancers 12, no. 3: 605.
https://doi.org/10.3390/cancers12030605
APA Style
Yun, U.-J., Lee, I. H., Lee, J.-S., Shim, J., & Kim, Y.-N.
(2020). Ginsenoside Rp1, A Ginsenoside Derivative, Augments Anti-Cancer Effects of Actinomycin D via Downregulation of an AKT-SIRT1 Pathway. Cancers, 12(3), 605.
https://doi.org/10.3390/cancers12030605